Elite Pharmaceuticals, Inc. (ELTP)
OTCMKTS · Delayed Price · Currency is USD
0.32472
+0.00082 (0.25%)
At close: Nov 20, 2026
Elite Pharmaceuticals Market Cap
Elite Pharmaceuticals has a market cap or net worth of $349.88 million as of November 20, 2026. It is the 16,234th most valuable company in the world and the 2,931st biggest in the United States. Its market cap has decreased by 43.75% in one year.
Market Cap
349.88M
Enterprise Value
320.19M
Revenue
144.77M
Global Rank
Country Rank
#2,931 United States
PE Ratio
10.24
ChartMarket Cap Chart
Since July 23, 1998, Elite Pharmaceuticals's market cap has increased from 9.58M to 349.88M, an increase of 3,553.97%. That is a compound annual growth rate of 13.53%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 349.88M | -33.58% |
| Dec 31, 2025 | 526.74M | -8.88% |
| Dec 31, 2024 | 578.04M | 306.60% |
| Dec 29, 2023 | 142.16M | 374.74% |
| Dec 30, 2022 | 29.95M | -10.40% |
| Dec 31, 2021 | 33.42M | -36.49% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 369.14M |
| Cyphaira | 46.55M |
| Raphael Pharmaceutical | 30.47M |
| Sofgen Pharma | 30.03M |
| High Sierra Technologies | 28.98M |
| Bio Essence | 25.29M |
| Earth Science Tech | 25.22M |
| Radnostix | 21.17M |